Insider Trading Alert - AMT, LNC And CGIX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 15, 2014, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $538.00 to $2,081,081.25.

Highlighted Stocks Traded by Insiders:

American Tower (AMT) - FREE Research Report

Katz Carolyn, who is Director at American Tower, sold 5,427 shares at $100.16 on Dec. 15, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 5,427-share transaction.

The shares most recently traded at $97.45, down $2.71, or 2.78% since the insider transaction. Historical insider transactions for American Tower go as follows:

  • 4-Week # shares bought: 2,900
  • 4-Week # shares sold: 3,750
  • 12-Week # shares bought: 2,900
  • 12-Week # shares sold: 8,750
  • 24-Week # shares bought: 2,900
  • 24-Week # shares sold: 26,750

The average volume for American Tower has been 2.1 million shares per day over the past 30 days. American Tower has a market cap of $39.6 billion and is part of the financial sector and real estate industry. Shares are up 23.5% year-to-date as of the close of trading on Friday.

American Tower Corporation is a real estate investment trust. It invests in the real estate markets across the globe. The firm through its subsidiaries owns, operates and develops wireless and broadcast communications real estate. The stock currently has a dividend yield of 1.52%. The company has a P/E ratio of 54.6. Currently, there are 10 analysts who rate American Tower a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMT - FREE

TheStreet Quant Ratings rates American Tower as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, solid stock price performance, good cash flow from operations and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full American Tower Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lincoln National (LNC) - FREE Research Report

Avery William J, who is Director at Lincoln National, sold 11,082 shares at $54.72 on Dec. 15, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 11,082-share transaction.

The shares most recently traded at $54.81, up $0.09, or 0.17% since the insider transaction. Historical insider transactions for Lincoln National go as follows:

  • 4-Week # shares sold: 4,348
  • 12-Week # shares sold: 23,848
  • 24-Week # shares sold: 34,303

The average volume for Lincoln National has been 2.0 million shares per day over the past 30 days. Lincoln National has a market cap of $14.8 billion and is part of the financial sector and insurance industry. Shares are up 6.57% year-to-date as of the close of trading on Friday.

Lincoln National Corporation, through its subsidiaries, is engaged in multiple insurance and retirement businesses in the United States. The company operates in Annuities, Retirement Plan Services, Life Insurance, and Group Protection segments. The stock currently has a dividend yield of 1.4%. The company has a P/E ratio of 10.1. Currently, there are 6 analysts who rate Lincoln National a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNC - FREE

TheStreet Quant Ratings rates Lincoln National as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Lincoln National Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cancer Genetics (CGIX) - FREE Research Report

Sitar Edward J, who is Chief Financial Officer at Cancer Genetics, bought 500 shares at $6.26 on Dec. 15, 2014. Following this transaction, the Chief Financial Officer owned 11,500 shares meaning that the stake was boosted by 4.55% with the 500-share transaction.

The shares most recently traded at $6.17, down $0.09, or 1.46% since the insider transaction. Historical insider transactions for Cancer Genetics go as follows:

  • 4-Week # shares bought: 72,546
  • 12-Week # shares bought: 72,546
  • 24-Week # shares bought: 72,546

The average volume for Cancer Genetics has been 56,900 shares per day over the past 30 days. Cancer Genetics has a market cap of $61.3 million and is part of the health care sector and health services industry. Shares are down 54.32% year-to-date as of the close of trading on Friday.

Cancer Genetics, Inc., an early-stage diagnostics company, focuses on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. Currently, there are 2 analysts who rate Cancer Genetics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CGIX - FREE

TheStreet Quant Ratings rates Cancer Genetics as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Cancer Genetics Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Asian Markets Decline in Morning Trading

Asian Markets Decline in Morning Trading

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Verizon Proves Resilient in Sell-Off; Decoding the Facebook Short -- ICYMI

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call